| Literature DB >> 33072200 |
Neophytos Stylianou1, Gregoria Samouti1, George Samoutis1.
Abstract
Cyprus has been affected by COVID-19 since March 2019. With a case fatality rate of 2.6% (until June 2020) and the social isolation measures enforced on the population, the population's mental health has been affected. We aimed to assess the mental health burden of the Cypriot population during the outbreak and to explore the potential influence factors. Using a web-based cross-sectional survey, we collected data from 216 volunteers regarding demographic data, COVID-19-related knowledge, generalized anxiety disorder (GAD), and major depressive symptoms. The overall prevalence of GAD and major depressive symptoms of the public were 13.89% and 8.33%, respectively. No demographic had shown any statistical significance with GAD. The younger age group of the study showed a statistically significant association with major depressive symptoms when compared to the adult population in both univariate and multivariable analyses. Our study identified a mental health burden of the Cypriot population, especially the younger age groups. As part of the preparedness for situations as the one we are experiencing and the future impact the pandemic may have on society, interventions should be focused on vulnerable groups of the population to alleviate the psychosocial effects. ©Carol Davila University Press.Entities:
Keywords: COVID-19; Cyprus; anxiety; depressive symptoms
Mesh:
Year: 2020 PMID: 33072200 PMCID: PMC7550154 DOI: 10.25122/jml-2020-0114
Source DB: PubMed Journal: J Med Life ISSN: 1844-122X
Demographics of mental health Covid-19 study participants.
| Variable | N (%) | |
|---|---|---|
| 89 (41.2) | ||
| 104 (48.15) | ||
| 23 (10.65) | ||
| 23 (10.65) | ||
| 8 (3.70) | ||
| 118 (54.63) | ||
| 39 (18.06) | ||
| 9 (4.17) | ||
| 19 (8.80) | ||
| 167 (77.31) | ||
| 49 (22.69) | ||
| 15 (6.94) | ||
| 69 (31.94) | ||
| 67 (31.02) | ||
| 23 (10.65) | ||
| 9 (4.17) | ||
| 33 (15.28) |
Demographics vs. participants’ information needs.
| Variable | No questions | Satisfied with information provided | General info | How to reduce chances of contracting the virus | |
|---|---|---|---|---|---|
| 23.60 | 40.45 | 16.85 | 19.10 | ||
| 21.15 | 30.77 | 31.73 | 16.35 | ||
| 39.13 | 21.74 | 26.09 | 13.04 | ||
| 13.04 | 26.09 | 47.83 | 13.04 | ||
| 21.82 | 36.36 | 22.42 | 19.39 | ||
| 44.44 | 33.33 | 11.11 | 11.11 | ||
| 47.37 | 21.05 | 26.32 | 5.26 | ||
| Healthcare | 60.00 | 26.67 | 6.67 | 6.67 | |
| 17.39 | 33.33 | 30.43 | 18.84 | ||
| 20.90 | 43.28 | 17.91 | 17.91 | ||
| 13.04 | 26.09 | 47.83 | 13.04 | ||
| 22.22 | 33.33 | 22.22 | 22.22 | ||
| 36.36 | 24.24 | 21.21 | 18.18 | ||
| 24.07 | 33.80 | 25.00 | 17.13 |
Prevalence of GAD and depression symptoms by demographics.
| Variable | GAD No (%) | GAD Yes (%) | X2/Fisher (P value) | Major Depressive Symptoms No (%) | Major Depressive Symptoms Yes (%) | X2/Fisher (P value) | |
|---|---|---|---|---|---|---|---|
| 88.76 | 11.24 | 1.426 | 89.89 | 10.11 | 0.121 | ||
| 82.69 | 17.31 | (0.233) | 91.35 | 8.65 | (0.728) | ||
| 86.96 | 13.04 | 0.634 | 78.26 | 21.74 | 0.092 | ||
| 84.24 | 15.76 | 92.12 | 7.88 | ||||
| 100 | 100 | ||||||
| 86.67 | 13.33 | 0.735 | 93.33 | 6.67 | 0.324 | ||
| 81.16 | 18.84 | 94.20 | 5.80 | ||||
| 86.57 | 13.43 | 89.55 | 10.45 | ||||
| 86.96 | 13.04 | 78.26 | 21.74 | ||||
| 100 | 0 | 100 | |||||
| 90.91 | 9.09 | 92.86 | 7.14 | ||||
| 86.11 | 13.89 | 91.67 | 8.33 |
Univariate analysis on GAD and Depressive symptoms.
| Variable | GAD OR | 95% CI | Depression OR | 95% CI | |
|---|---|---|---|---|---|
| Gender | |||||
| 1.65 | 0.72 - 3.80 | 0.84 | 0.32 - 2.22 | ||
| Ref | |||||
| 0.80 | 0.22 - 2.89 | 3.25 | 1.04 - 10.17 | ||
| Ref | |||||
| 0.66 | 0.13 - 3.30 | 1.16 | 0.12 - 11.19 | ||
| 0.67 | 0.26 - 1.69 | 1.90 | 0.53 - 6.80 | ||
| 0.65 | 0.17 - 2.51 | 4.51 | 1.10 - 18.57 | ||
Multivariable analysis of GAD and depressive symptoms.
| Variable | GAD OR | 95% CI | Depression OR | 95% CI | |
|---|---|---|---|---|---|
| 1.65 | 0.67 - 3.87 | 0.70 | 0.25 - 1.96 | ||
| Ref | |||||
| 0.46 | 0.09 - 2.22 | 4.91 | 1.18 - 20.48 | ||
| 0.76 | 0.15 - 3.85 | 1.16 | 0.12 -11.37 | ||
| 0.71 | 0.26 – 1.69 | 1.90 | 0.55 - 7.13 | ||